Abstract
BVDU [(E)-5-(2-bromovinyl)-2′-deoxyuridine] has a potent and selective activity against herpes simplex (type 1) in both cell culture systems and animal models. The efficacy of topical BVDU treatment (0.1% eye drops) has been evaluated in 37 patients with different forms of herpes simplex keratitis. Of these patients, 35 were followed for 2–9 months (average 6.5 months). Most of the patients had first been treated with topical IDU (idoxuridine) or ara-A (adenine arabinoside), albeit unsuccessfully, before BVDU treatment was started. Upon BVDU treatment, dendritic corneal ulcers healed in 7.8 days (on average) and the geographic corneal ulcers in 10.8 days. BVDU also exerted a pronounced healing effect on stromal keratitis, whether it was used alone or in combination with topical corticosteroids. No early recurrences were observed. Late recurrences were seen in four patients who again responded quickly to BVDU treatment. No toxic side effects, whether local or systemic, were noted in any of the patients treated with BVDU. These results establish the efficacy of BVDU in the local treatment of herpetic keratitis in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allaudeen HS, Kozarich JW, Bertino JR, De Clercq E (1980) On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2′-deoxyuridine. In Proceedings of the International Conference on Human Herpesviruses, held at Emory University, Atlanta, Georgia, March 17–21
Binder PS (1977) Herpes simplex keratitis. Surv Ophthalmol 21:313
De Clercq E, Descamps J (1981, in press) On the mechanism of antiherpes action of E-5-(2-bromovinyl)-2′-deoxyuridine. In Proceedings of the International Symposium of the German Ophthalmologic Society on Herpetic Eye Diseases, held in Freiburg (im Breisgau), April 12–14, 1980. JF Bergmann Verlag, München
De Clerq E, Descamps J, Barr PJ, Jones AS, Serafinowski P, Walker RT, Huang G-F, Torrence PF, Schmidt CL, Mertes MP, Kulikowski T, Shugar D (1979a) Comparative study of the potency and selectivity of antiherpes compounds. In Skoda J, and Langen P (eds): Antimetabolites in Biochemistry, Biology and Medicine. Pergamon Press, Oxford and New York pp 275–285
De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS, Walker RT (1979b) (E)-5-(2-Bromovinyl)-2′-deoxyuridine: a potent and selective antiherpes agent. Proc Natl Acad Sci USA 76:2947
De Clercq E, Descamps J, Verhelst G, Walker RT, Jones AS, Torrence PF, Shugar D (1980) Comparative efficacy of different antiherpes drugs against different strains of herpes simplex virus. J Infect Dis 141:563
Kok-van Alphen CC, Völker-Dieben HJM (1981, in press) Impairment of tear-production in corneal herpetic disease. In: Proceedings of the International Symposium of the German Ophthalmologic Society on Herpetic Eye Diseases, held in Freiburg (im Breisgau), April 12–14, 1980. JF Bergmann Verlag, München
Maudgal PC, De Clercq E, Descamps J, Missotten E, De Somer P, Busson R, Vanderhaeghe H, Verhelst G, Walker RT, Jones AS (1980) (E)-5-(2-Bromovinyl)-2′-deoxyuridine in the treatment of experimental herpes simplex keratitis. Antimicrob Agents Chemother 17:8
Maudgal PC, De Clercq E, Descamps J, and Missotten L (1979) Comparative evaluation of BVDU [(E)-5-(2-bromovinyl)-2′-deoxyuridine] and IDU (5-iodo-2′-deoxyuridine) V in the treatment of experimental herpes simplex keratitis in rabbits. Bull Soc Belge Ophtal 186:109
McNeill JI, Kaufman HE (1979) Local antivirals in a herpes simplex stromal model. Arch Ophthalmol 97:727
Metcalf JF, McNeill JI, Kaufman HE (1976) Experimental disciform edema and necrotizing keratitis in the rabbit. Invest Ophthalmol 15:979
Meyers RL, Chitjian PA, Fiorello P (1979) Studies on immunopathogenesis of chronic and recurrent herpes simplex virus keratitis in man: immunoperoxidase antibody study. In: Concilium Ophthalmologica Acta. Part II. Amsterdam, Excerpta Medica pp 1739–1743
Meyers-Elliott RH, Pettit TH, Maxwell WA (1980) Viral antigens in the immune ring of herpes simplex stromal keratitis. Arch Ophthalmol 98:897
Singh D, Singh M (1981, in press) Herpetic keratitis causing lacrimal hyposecretion and xerosis. In: Proceedings of the International Symposium of the German Ophthalmologic Society on Herpetic Eye Diseases, held in Freiburg (im Breisgau), April 12–14, 1980. JF Bergmann Verlag, München
Walker RT, Barr PJ, De Clercq E, Descamps J, Jones AS, Serafinowski P (1978) The synthesis and properties of some antiviral nucleosides. Nucleic Acids Res special publication no 4:103
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maudgal, P.C., Missotten, L., De Clercq, E. et al. Efficacy of (E)-5-(2-bromovinyl)-2′-deoxyuridine in the topical treatment of herpes simplex keratitis. Albrecht von Graefes Arch. Klin. Ophthalmol. 216, 261–268 (1981). https://doi.org/10.1007/BF00455033
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00455033